US Stock Futures and Bond Yields Slide on Reports of Updated Russian Nuclear Doctrine MercedesBenz Signals Potential Shift Toward Defence Sector Amid Automotive Pressures Indian Steel Stocks Rise as Government Extends Minimum Import Price on 66 Products T Rowe Price Group TROW Highlighted as HighYield Retirement Income Pick with 503 Dividend Yield Polymarket Traders Bet SpaceX OpenAI Could Surpass Berkshire Hathaway in FirstDay Valuation Tulsi Gabbard Resigns as Trumps Intelligence Chief Potential Implications for National Security and Defense Contracting SDST Q1 2026 Earnings WiderthanExpected Loss Weighs on Shares GILD Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response SKE Q1 2026 Earnings Significant EPS Miss Amid Exploration Stage Operations CVM Q4 2024 Earnings Narrowing Losses with a 19 EPS Surprise UTSI Q4 2019 Earnings Significant EPS Miss Highlights Operational Challenges The Oncology Institute Inc TOI Q1 2026 Earnings Narrowing Losses Drive Substantial EPS Beat MicroCloud Hologram Inc Warrant HOLOW Holds at 008 Stability Amidst Minimal Movement Allspring Global Dividend Opportunity Fund EOD Edges Higher Amid Steady Momentum Southwest Gas Holdings Inc SWX Rises 115 as Utility Stocks Hold Steady Near Key Resistance Western Asset Diversified Income Fund WDI Holds Steady at 1349 Amid Modest Uptick TX Stock Slipped 149 Steel Sector Headwinds Pressure Ternium Dropbox CEO Drew Houston to Transition to Executive Chairman After 19Year Tenure PNR Q1 2026 Earnings EPS Beats Estimates by 33 as Shares Slip Slightly Magyar Bancorp MGYR Holds Steady Near Support Amid Low Volatility US Equity Funds See Outflows as Investors Eye Higher Bond Yields Market Expert Advises Caution Amid Geopolitical Risks June Quarter Earnings to Guide Market Sentiment Goldman Sachs Tapped to Lead SpaceX IPO in Potential Historic Market Debut US Treasury Yields Decline as Bond Market Volatility Eases Bond Markets Signal Persistent Inflation Pressure Raising Stakes for US Policymakers Boston Beer Company SAM Faces Price Target Cut by Morgan Stanley Amid Cost and Macro Headwinds Tony Blairs Economic Blueprint Diagnosis on Point Prescription Under Fire